Go to content
UR Home

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

URN to cite this document:
urn:nbn:de:bvb:355-epub-585910
DOI to cite this document:
10.5283/epub.58591
Corbacioglu, Selim ; Lode, Holger ; Ellinger, Susanne ; Zeman, Florian ; Suttorp, Meinolf ; Escherich, Gabriele ; Bochennek, Konrad ; Gruhn, Bernd ; Lang, Peter ; Rohde, Marius ; Debatin, Klaus Michael ; Steinbach, Daniel ; Beilken, Andreas ; Ladenstein, Ruth ; Spachtholz, Rainer ; Heiss, Peter ; Hellwig, Dirk ; Tröger, Anja ; Koller, Michael ; Menhart, Karin ; Riemenschneider, Markus J. ; Zoubaa, Saida ; Kietz, Silke ; Jakob, Marcus ; Sommer, Gunhild ; Heise, Tilman ; Hundsdörfer, Patrick ; Kühnle, Ingrid ; Dilloo, Dagmar ; Schönberger, Stefan ; Schwabe, Georg ; von Luettichau, Irene ; Graf, Norbert ; Schlegel, Paul-Gerhardt ; Frühwald, Michael ; Jorch, Norbert ; Paulussen, Michael ; Schneider, Dominik T. ; Metzler, Markus ; Leipold, Alfred ; Nathrath, Michaela ; Imschweiler, Thomas ; Christiansen, Holger ; Schmid, Irene ; Crazzolara, Roman ; Niktoreh, Naghmeh ; Cario, Gunnar ; Faber, Joerg ; Demmert, Martin ; Babor, Florian ; Fröhlich, Birgit ; Bielack, Stefan ; Bernig, Toralf ; Greil, Johann ; Eggert, Angelika ; Simon, Thorsten ; Foell, Juergen
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
(406kB)
Date of publication of this fulltext: 03 Jul 2024 08:04



Abstract

Background Neuroblastoma is the most common extracranial solid tumour in children. Relapsed or refractory neuroblastoma is associated with a poor outcome. We assessed the combination of irinotecan–temozolomide and dasatinib–rapamycin (RIST) in patients with relapsed or refractory neuroblastoma. Methods The multicentre, open-label, randomised, controlled, phase 2, RIST-rNB-2011 trial recruited ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons